Features | Partner Sites | Information | LinkXpress
Sign In

Neurostimulation Systems Earn CE Marking for Use with Full-Body MRI Scans

By Medimaging International staff writers
Posted on 13 Feb 2013
Image: The SureScan line of neurostimulation systems for the treatment of chronic pain are designed for compatibility with full-body MRI scans (Photo courtesy of Medtronic).
Image: The SureScan line of neurostimulation systems for the treatment of chronic pain are designed for compatibility with full-body MRI scans (Photo courtesy of Medtronic).
The first implantable neurostimulation systems for use in the treatment of leg pain and/or chronic back are designed to be compatible with full-body magnetic resonance imaging (MRI) scans under specific conditions. The systems were recently introduced in Europe.

Medtronic, Inc.’s (Minneapolis, MN, USA) neurostimulation systems for the treatment of chronic pain recently received Conformité Européenne (CE) Marking approval for compatibility with full-body MRI scans. Neurostimulation systems enhanced with this technology and using Vectris SureScan MRI leads include: RestoreSensor SureScan MRI, PrimeAdvanced SureScan MRI, RestoreAdvanced SureScan MRI, and RestoreUltra SureScan MRI. Medtronic SureScan neurostimulation systems for the treatment of chronic pain are not approved by the US Food and Drug Administration for use in the United States.

“Neurostimulation therapy has become a mainstay of chronic pain management, and the introduction of full-body, MRI-compatible spinal cord stimulation systems is an important advancement that will help ensure neurostimulation patients have access to the diagnostic tools needed to quickly identify potentially critical health conditions,” said Dr. JP Van Buyten from the AZ Niklaas Hospital (Sint-Niklaas, Belgium).

As recent technologic development have increased MRI effectiveness and patient comfort, MRI use has increased dramatically in recent years. It is estimated that 60 million MRI scans are performed worldwide yearly. In Western Europe alone, 29 million scans were performed in 2010, with the number of scans doubling every five years.

Medtronic SureScan neurostimulation systems fulfill a vital medical need for full-body MRI compatibility by enabling patients who are receiving Medtronic neurostimulation therapy for chronic back and/or leg pain (also called spinal cord stimulation [SCS]) to have access to the advantages of full-body MRI. SCS patients, up to now, were denied full-body MRI scans because of worries that the system being affected by the large magnets involved in MRI.

“Delivering systems that are compatible with a full-body MRI scan means that spinal cord stimulation patients will not have to compromise when it comes to their healthcare, and they can feel secure knowing that MRI is a diagnostic option,” said Julie Foster, general manager and vice president, pain stimulation and targeted drug delivery in the neuromodulation business of Medtronic, Inc. “Medtronic’s development of these systems is another example of our commitment to advancing increasingly innovative and cost effective solutions that make it easier for clinicians to safely, effectively, and efficiently diagnose and treat the patients they serve.”

Medtronic SureScan neurostimulation systems include enhancements to existing devices as well as specially designed leads to reduce or eliminate the dangers generated by the MRI setting. The devices also include a proprietary SureScan programming feature, which sets the device into a suitable mode for the MRI environment.

Medtronic neurostimulation therapy for chronic pain uses a medical device positioned under a patient’s skin to deliver mild electrical impulses to the spinal cord, which act to block pain signals from going to the brain. Patients feel a tingling sensation from the neurostimulation Instead of pain in areas where they had earlier experienced pain.

Related Links:



view channel
Image: Multimodal CT images obtained 2 hours 18 minutes after symptom onset in an 87-year-old woman with an NIH Stroke Scale of 15 and left hemisphere symptoms (Photo courtesy of Radiology 2015:257;2;510-520, and RSNA 2015).

Faster and Simpler Treatment for Stroke Patients Using Multiphase CT

The results of a new study show that multiphase Computed Tomography (CT) angiography brain-imaging could enable clinicians to treat Acute Ischemic Stroke (AIS) patients faster, and better, potentially saving lives.... Read more

Nuclear medicine

view channel
Image: The whole body of a rat can be imaged for blood clots with one PET scan, overlaid here on an MRI image, using the FBP8 probe. The arrow points to a blood clot (Photo courtesy of the American Chemical Society).

Single PET Scan Could Replace Multiple Modalities in Detecting Blood Clots

Researchers have presented an experimental technique that could be used to discover blood clots using a single, fast, whole-body scan, at the 250th National Meeting and Exposition of the American Chemical... Read more

General/Advanced Imaging

view channel

Leading Vendor to Implement and Install Enterprise Imaging Platform for UK NHS

An agreement has been announced by a leading imaging platform provider for the implementation of the first Enterprise Imaging platform, part of a long-term agreement for the management of imaging data, for the UK City Hospitals Sunderland NHS Foundation Trust. The agreement covers the capture, storage, and exchange of... Read more

Imaging IT

view channel

Carestream Updates Healthcare IT Platform

Carestream has released updates for an advanced Internet Technology (IT) healthcare platform at the Röntgenveckan Radiology congress in Malmo (Sweden). The IT platform facilitates collaboration by enabling sharing of critical patient information such as Radiology images, videos, reports, and services with groups outside... Read more

Industry News

view channel

New Distribution and Commercialization Agreement for Medical Imaging Contrast Agent in China

China’s second largest pharmaceutical distribution group and an international medical imaging pharmaceutical group have announced an agreement for the distribution and commercialization of Lipiodol Ultra-Fluid, from September 2015. Lipiodol Ultra-Fluid is used in interventional radiology procedures as a contrast agent,... Read more
Copyright © 2000-2015 Globetech Media. All rights reserved.